Alpine Immune Sciences In...

NASDAQ: ALPN · Real-Time Price · USD
64.97
0.01 (0.02%)
At close: May 17, 2024, 10:00 PM

Alpine Immune Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
43.92M 13.38M 67.91M
Short-Term Investments
283.49M 224.26M 94.4M
Long-Term Investments
40.56M 35.48M 52.87M
Other Long-Term Assets
268K 254K 11.02M
Receivables
749K 709K 25.32M
Inventory
-167K -317K -323K
Other Current Assets
1.87M 2.96M 4.71M
Total Current Assets
330.03M 240.99M 192.01M
Property-Plant & Equipment
8.99M 9.8M 10.55M
Goodwill & Intangibles
n/a n/a -10.77M
Total Long-Term Assets
49.82M 45.69M 63.89M
Total Assets
379.85M 286.69M 255.9M
Account Payables
3.59M 4.29M 3.35M
Deferred Revenue
16.29M 35.57M 51.77M
Short-Term Debt
912K 4.14M 5.24M
Other Current Liabilities
21.19M 14M 9.42M
Total Current Liabilities
41.98M 58M 69.78M
Long-Term Debt
9M 10.09M 14.39M
Other Long-Term Liabilities
n/a 39.19M -3.38M
Total Long-Term Liabilities
9.93M 49.27M 65.22M
Total Liabilities
51.91M 107.27M 135M
Total Debt
9.91M 14.22M 19.63M
Common Stock
60K 46K 30K
Retained Earnings
-256.14M -223.96M -166.2M
Comprehensive Income
397K -1.12M -273K
Shareholders Equity
327.94M 179.42M 120.9M
Total Investments
324.05M 259.75M 147.26M